Clinical trial

Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ…

NCT00053352 · Children's Oncology Group, Other · Completed

Key facts

NCT number NCT00053352
Title Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
Official title A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Lead sponsor Children's Oncology Group, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Childhood Embryonal Tumor, Childhood Extracranial Germ Cell Tumor, Childhood Extragonadal Germ Cell Tumor, Childhood Malignant Ovarian Germ Cell Tumor, Childhood Malignant Testicular Germ Cell Tumor, Childhood Teratoma, Ovarian Embryonal Carcinoma, Ovarian Yolk Sac Tumor, Stage II Malignant Testicular Germ Cell Tumor, Stage IIA Ovarian Germ Cell Tumor and 8 more
Intervention type Biological, Drug, Other, Procedure
Interventions conventional surgery, cisplatin, etoposide, bleomycin sulfate, laboratory biomarker analysis
Enrollment 302
Start date Nov 3, 2003
Primary completion Oct 1, 2013
Completion Jun 30, 2021
First posted Jan 28, 2003
Last update posted Jul 13, 2021
Countries Australia, Canada, New Zealand, Puerto Rico, Switzerland, United States

At a glance

  • 100–999 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies